Drug Profile
Vaccinia virus-interleukin 12 gene therapy - MultiVir
Alternative Names: VV-IL12Latest Information Update: 14 Sep 2023
Price :
$50
*
At a glance
- Originator MultiVir
- Class Gene therapies
- Mechanism of Action Gene transference
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Pancreatic cancer
Most Recent Events
- 14 Sep 2023 Discontinued - Preclinical for Pancreatic cancer in USA (Parenteral) before September 2023 (MultiVir website, September 2023)
- 28 Apr 2019 No recent reports of development identified for preclinical development in Pancreatic-cancer in USA (Parenteral)
- 30 Mar 2015 Preclinical trials in Pancreatic cancer in USA (Parenteral)